Back to ETFs
EquityBTAI
BioXcel Therapeutics, Inc.
Ticker
BTAI
Asset Class
Equity
Assets Under Management
45.12M
Holdings
10+
About This Fund
BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.
BioXcel Therapeutics, Inc. Price Chart
Loading chart…